We selected three HIF-1α downstream genes (GLUT-1, CA9 and VEGF) since their overexpression is known to contribute to cancer progression through various mechanisms including metabolism reprogramming (for GLUT-1 and CA9) and angiogenesis (for VEGF) [2,38,39,40]. This evidence concerns the gene SLC2A1 and cancer.